Literature DB >> 27742703

Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.

Dervla O'Malley1,2.   

Abstract

Irritable bowel syndrome (IBS) is a common disorder characterized by recurrent abdominal pain, bloating, and disturbed bowel habit, symptoms that impact the quality of life of sufferers. The pathophysiological changes underlying this multifactorial condition are complex and include increased sensitivity to luminal and mucosal factors, resulting in altered colonic transit and visceral pain. Moreover, dysfunctional communication in the bidirectional signaling axis between the brain and the gut, which involves efferent and afferent branches of the peripheral nervous system, circulating endocrine hormones, and local paracrine and neurocrine factors, including immune and perhaps even microbial signaling molecules, has a role to play in this disorder. This minireview will examine recent advances in our understanding of the pathophysiology of IBS and assess how cross talk between hormones, immune, and microbe-derived factors and their neuromodulatory effects on peripheral nerves may underlie IBS symptomatology.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  GLP-1; interleukins; leptin; myenteric; submucosal

Mesh:

Year:  2016        PMID: 27742703      PMCID: PMC5130550          DOI: 10.1152/ajpgi.00272.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  89 in total

Review 1.  Microbial endocrinology and infectious disease in the 21st century.

Authors:  Mark Lyte
Journal:  Trends Microbiol       Date:  2004-01       Impact factor: 17.079

2.  Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents.

Authors:  Azucena Perez-Burgos; Bingxian Wang; Yu-Kang Mao; Bhavik Mistry; Karen-Anne McVey Neufeld; John Bienenstock; Wolfgang Kunze
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

Review 3.  Peripheral mechanisms in irritable bowel syndrome.

Authors:  Michael Camilleri
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

Review 4.  Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.

Authors:  Valeria D Felice; Eamonn M Quigley; Aideen M Sullivan; Gerard W O'Keeffe; Siobhain M O'Mahony
Journal:  Parkinsonism Relat Disord       Date:  2016-03-16       Impact factor: 4.891

5.  Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Buyi Zhang; G Nicholas Verne
Journal:  Pain       Date:  2009-11       Impact factor: 6.961

Review 6.  Brain-gut axis and its role in the control of food intake.

Authors:  S J Konturek; J W Konturek; T Pawlik; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2004-03       Impact factor: 3.011

7.  The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat.

Authors:  Lieve Desbonnet; Lillian Garrett; Gerard Clarke; John Bienenstock; Timothy G Dinan
Journal:  J Psychiatr Res       Date:  2008-05-05       Impact factor: 4.791

8.  Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

9.  A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Eric Marietta; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Denise Janzow; Deborah Eckert; Duane Burton; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2013-01-25       Impact factor: 22.682

10.  Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

Authors:  Louise Maagaard; Dorit V Ankersen; Zsuzsanna Végh; Johan Burisch; Lisbeth Jensen; Natalia Pedersen; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

View more
  7 in total

1.  Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Kai Ma; Yongkang Liu; Wei Shao; Jianhua Sun; Jing Li; Xiaokun Fang; Jing Li; Zhongqiu Wang; Daoqiang Zhang
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

2.  Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  De-Rong Liu; Xiao-Juan Xu; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

3.  Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Michele Linsalata; Benedetta D'Attoma; Caterina Clemente; Antonella Orlando
Journal:  Dis Markers       Date:  2018-11-28       Impact factor: 3.434

4.  Gastric Mucosal Immune Profiling and Dysregulation in Idiopathic Gastroparesis.

Authors:  Andres Gottfried-Blackmore; Hong Namkoong; Emerald Adler; Brock Martin; John Gubatan; Nielsen Fernandez-Becker; John O Clarke; Juliana Idoyaga; Linda Nguyen; Aida Habtezion
Journal:  Clin Transl Gastroenterol       Date:  2021-05-12       Impact factor: 4.396

Review 5.  Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids.

Authors:  Róisín Ní Dhonnabháín; Qiao Xiao; Dervla O'Malley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 5.555

6.  Bile acids, bioactive signalling molecules in interoceptive gut-to-brain communication.

Authors:  Susan A Joyce; Dervla O'Malley
Journal:  J Physiol       Date:  2022-04-30       Impact factor: 6.228

7.  Magnetic resonance imaging analysis of brain function in patients with irritable bowel syndrome.

Authors:  Danping Wang; Xie Zhang; Xuesong Zhang; Zhigang Huang; Yufei Song
Journal:  BMC Gastroenterol       Date:  2017-12-08       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.